MicroRNAs are foreseen as promising biomarkers for diagnosis, prognosis and follow up of cancer diseases. First things first: be able to detect these biomarkers reliably and sensitively. The objective of this work is to propose a novel technology for the accurate quantification of these microRNA molecules, combining DNA nanotechnology and droplet microfluidics.

See the ESPCI release @ https://www.espci.psl.eu/en/news/2020/dna-nanotechnology-to-detect-cancer-biomarkers